HP518 yakawanikwa uye yakagadziridzwa neHinova yakanangwa protein degradation drug discovery chikuva. Iyo ine mukana wekukunda kushomeka kwemishonga yekenza yeprostate nekuda kwekumwe kuchinjika kweAR.
Chimeric degraders ane bifunctional mamorekuru madiki anokurudzira kushatiswa kwechinangwa cheprotein ane potency yakakura uye yakakwirira kusarudza. Tekinoroji iyi ine mukana wekunangisa zvibodzwa zvisingadhurike uye kukunda nyaya yekuramba mishonga yemishonga midiki yemamorekuru.
"Ichi chiitiko chakakosha mukufambira mberi kwekuedza kwedu kubva mukuwanikwa kwezvinodhaka kusvika kuongororo yekiriniki," akadaro Yuanwei Chen, Ph.D., Mutungamiriri uye CEO weHinova. "Tinofara nazvo uye takazvipira kuunza nzira nyowani dzekurapa kuvarwere pasi rese!"
Kuburikidza neyakanangwa protein degradation zvinodhaka zvekuwanikwa chikuva, Hinova inogona kuongorora mapuroteni ekudzikisira chiitiko nekukurumidza uye kuita dhizaini inoshanda uye optimization yechimeric degraders. Uyezve, Hinova ane ruzivo rwakadzama mukugadzirwa kwemakemikari kutonga kweChimeric degrader compounds.